5 completed, 3 recruiting, 1 not yet recruiting, 1 terminated. 2 Phase 4, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Terminated 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Bloodstream Infections: new trials by email Literature Review of Bloodstream Infections trials Research Report on Bloodstream Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| INfections in Patients Treated With CAR-T Relapsed Multiple Myeloma, Refractory Multiple Myeloma | Not yet recruiting | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 290 | 2026-11-01 | 2026-07-20 | |
| Clinical Efectiveness of a Multiplex PCR-Based Rapid Diagnostic Method in Bloodstream Infections Multiplex PCR-Based Rapid Diagnostic Test, Standard Microbiological Diagnostic Methods - Bloodstream Infections, Bacteremia and Sepsis | Recruiting | Istanbul Medipol University Hospital | 300 | 2026-01-01 | 2026-02-13 | |
| Blood DdPCR for Early Identification and Dynamic Surveillance of Pathogenic Bacteria in ICU Septic Patients: a Single-centre, Prospective, Observational Study Sepsis, Bloodstream Infections | Recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 60 | 2024-09-15 | 2025-03-17 | |
| INfectious DIsease REgistry BIObank Bloodstream Infections, Central Nervous System Infections | Recruiting | IRCCS San Raffaele | 10000 | 2024-02-01 | 2026-04-20 | |
| RCT Cefiderocol vs BAT for Treatment of Gram Negative BSI Cefiderocol, Best Available Therapy - Bloodstream Infections | Phase 2 | Completed | The University of Queensland | 513 | 2019-10-28 | 2024-02-13 |
| Clinical Impact of Rapid Identification of Positive Blood Cultures vs. Internal Laboratory Standard conventional identification method: biochemical profiling or MALDI-TOF MS, new identification method: Biofire FilmArray© BCID panel, new identification method: metagenomic WGS - Bloodstream Infections | Completed | University Hospital, Basel, Switzerland | 800 | 2019-10-17 | 2024-05-09 | |
| ANTIBIOTIC-RESISTANT ENTEROBACTERALES BLOODSTREAM INFECTIONS AND RISK FACTORS IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT Bloodstream Infections, Enterobacteriaceae Infections | Completed | Ankara City Hospital Bilkent | 314 | 2019-09-01 | 2025-09-15 | |
| Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial Response Meropenem, Piperacillin-tazobactam combination product - Bloodstream Infections | Phase 4 | Completed | The University of Queensland | 100 | 2015-04-01 | 2023-05-10 |
| RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp. Meropenem, Piperacillin-tazobactam combination product - Bloodstream Infections | Phase 4 | Terminated | The University of Queensland | 391 | 2014-02-01 | 2017-11-27 |
| Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants Glutamine, L-alanine - Bloodstream Infections, Short Bowel Syndrome | Not applicable | Completed | Children's Hospital Medical Center, Cincinnati | 10 | 2012-04-01 | 2020-06-11 |
Sepsis (10) · Bacteremia (1) · Central Nervous System Infections (1) · Cytokine Release Syndrome (1) · Endocarditis (1) · Enterobacteriaceae Infections (1) · Fungemia (1) · Hyperphagia (1) · Lymphoma, B-Cell (1) · Multiple Myeloma (1) · Short Bowel Syndrome (1)
Infections (10) · Inflammation (10) · Pathologic Processes (10) · Pathological Conditions, Signs and Symptoms (10) · Systemic Inflammatory Response Syndrome (10) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Cardiovascular Diseases (2) · Blood Protein Disorders (1) · Central Nervous System Diseases (1) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Gram-Negative Bacterial Infections (1) · Heart Diseases (1) · Hematologic Diseases (1)
Meropenem (2) · Piperacillin, Tazobactam Drug Combination (2) · Alanine (1) · Cefiderocol (1) · Glutamine (1)
The University of Queensland (3) · Ankara City Hospital Bilkent (1) · Children's Hospital Medical Center, Cincinnati (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · IRCCS San Raffaele (1) · Istanbul Medipol University Hospital (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · University Hospital, Basel, Switzerland (1)
Turkey (Türkiye) (4) · Australia (3) · Italy (3) · Singapore (3) · Canada (1) · China (1) · Lebanon (1) · Malaysia (1) · New Zealand (1) · Saudi Arabia (1) · South Africa (1) · Switzerland (1) · Taiwan (1) · Thailand (1) · United States (1)
David Paterson, Professor (2) · Adrian Egli, PD Dr. med (1) · Conrad R Cole, MD (1) · David L Paterson, MD, PhD (1) · Marco Ripa, MD (1) · Meyha Sahin (1) · Zeno Adrien Igor Pasquini (1)
PMID 25623485, PMID 30208454, PMID 34395716, PMID 34876196, PMID 37884860, PMID 40803735, PMID 41067237
2019 (1), R21DK088027 (1)